Description
GW405833 is a selective cannabinoid receptor 2 (CB2) agonist. It shows activity in pancreatic cancer mouse models and reduces the number of Ca2+ ocilllations in pancreatic acinar cells, which is a cause of pancreatitis.
Product Unit Size | Cost | Quantity | Stock |
---|
GW405833 is a selective cannabinoid receptor 2 (CB2) agonist. It shows activity in pancreatic cancer mouse models and reduces the number of Ca2+ ocilllations in pancreatic acinar cells, which is a cause of pancreatitis.
Cas No. | 180002-83-9 |
---|---|
Purity | ≥98% |
Formula | C23H24Cl2N2O3 |
Formula Wt. | 447.356 |
Chemical Name | (2,3-dichlorophenyl)-[5-methoxy-2-methyl-3-(2-morpholin-4-ylethyl)indol-1-yl]methanone |
IUPAC Name | (2,3-dichlorophenyl)-[5-methoxy-2-methyl-3-(2-morpholin-4-ylethyl)indol-1-yl]methanone |
Synonym | L-768,242, GW405833 |
Solubility | 50mM in DMSO, 50mM in ethanol |
Appearance | Tan powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Huang Z, Wang H, Wang J et al. Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells. Sci Rep. 2016 Jul 19:6:29757. PMID: 27432473.
Mancini I, Brusa R, Quadrato G et al. Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242. Br J Pharmacol. 2009 Sep;158(1):382-91. PMID: 19552692.
Calcitonin-family peptide frgament, involved in...
Mycotoxin produced by Penicillum and Aspergillu...
Aromatase inhibitor.
Pentacyclic triterpene found in various plant s...
PDK1 inhibitor.
VEGFR inhibitor.
Bisaniline pyrimidine; pan-kinase inhibitor.
1-Naphthalenacetic acid derivative, NSAID; COX-...
Calcineurin inhibitor, potential TRPV1 agonist....
Recombinant HCV antigen fragment.
PP2A inhibitor.
EZH2 inhibitor
Triazolothienodiazepine; BRD inhibitor.
Endogenous tachykinin peptide, involved in infl...
Melatonin analog; MT1/2 agonist.
Macrolide antibiotic; peptidyl transferase inhi...
Peptide hormone found in eels; GnRH agonist, we...
Selective estrogen receptor modulator.
Statin; HMG-CoA reductase inhibitor.
p110γ PI3K inhibitor.